The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 1,062 | 29,801 | SH | SOLE | 29,801 | 0 | 0 | ||
| AERIE PHARMACEUTICALS INC | COM | 00771V108 | 364 | 14,962 | SH | SOLE | 14,962 | 0 | 0 | ||
| ALEXION PHARMACEUTICALS INC | COM | 015351109 | 1,640 | 8,599 | SH | SOLE | 8,599 | 0 | 0 | ||
| ARATANA THERAPEUTICS INC | COM | 03874P101 | 1,219 | 218,515 | SH | SOLE | 218,515 | 0 | 0 | ||
| ATHENAHEALTH INC | COM | 04685W103 | 789 | 4,900 | SH | SOLE | 4,900 | 0 | 0 | ||
| DEXCOM INC | COM | 252131107 | 1,560 | 19,046 | SH | SOLE | 19,046 | 0 | 0 | ||
| EDWARDS LIFESCIENCES CORP | COM | 28176E108 | 303 | 38,322 | SH | SOLE | 38,322 | 0 | 0 | ||
| INCYTE CORP | COM | 45337C102 | 1,600 | 14,756 | SH | SOLE | 14,756 | 0 | 0 | ||
| LILLY ELI & CO | COM | 532457108 | 750 | 8,898 | SH | SOLE | 8,898 | 0 | 0 | ||
| REGENERON PHARMACEUTICALS | COM | 75886F107 | 1,583 | 2,916 | SH | SOLE | 2,916 | 0 | 0 | ||